氟曲马唑,CAS 登记号 119006-77-8,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 氟曲马唑 的 CAS 号:119006-77-8,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Flutrimazole · CAS 119006-77-8 · C22H16F2N2. UNII 776S0UP252.
| CAS Registry Number | 119006-77-8 |
|---|---|
| PubChem CID | 3401 |
| Molecular formula | C22H16F2N2 |
| IUPAC name | 1-[(2-fluorophenyl)-(4-fluorophenyl)-phenylmethyl]imidazole |
| UNII (FDA) | 776S0UP252 |
| Molecular Weight | 346.4 |
|---|---|
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 346.12815484 |
| Monoisotopic Mass | 346.12815484 |
| Topological Polar Surface Area | 17.8 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H315 (100%), H319 (100%), H335 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
flutrimazole; 119006-77-8; Flutrimazol; UR-4056; Flutrimazolum; 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole; 1-((2-Fluorophenyl)(4-fluorophenyl)phenylmethyl)-1H-imidazole; 1-(o-Fluoro-alpha-(p-fluorophenyl)-alpha-phenylbenzyl)imidazole; 776S0UP252; CHEBI:82864; DTXSID30869622; RefChem:141078; D01AC16; DTXCID10817580; G01AF18; 1-[(2-fluorophenyl)-(4-fluorophenyl)-phenylmethyl]imidazole
CAS 119006-77-8; molecular formula C22H16F2N2; molecular weight — g/mol.
flutrimazole, 119006-77-8, Flutrimazol, UR-4056, Flutrimazolum, 1-[(2-fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole.
Hazard statements reported: H302, H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.